1/5/2012

Actavis secured FDA marketing approval for 20-, 30- and 40-milligram capsules of extended-release methylphenidate hydrochloride. It is a generic equivalent of Novartis' attention-deficit/hyperactivity disorder medicine Ritalin LA.

Full Story:
Drug Store News

Related Summaries